高リスク腸上皮化生患者のリスク層別化のための分子検査の検証（GCEP2研究）

基本情報

NCT ID: NCT05782465
ステータス: 実施中（募集終了）
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 500
治験依頼者名: National University Hospital, Singapore

概要

This study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in the molecular-test-positive group will be significantly higher than that in the molecular-test-negative group. Such a test has the potential to guide clinicians to better manage patients with IM by allowing endoscopic surveillance to be focused on individuals at very-high-risk of developing stomach cancer, at the same time avoiding or reducing endoscopies for those at lower risk.

対象疾患

Stomach Neoplasm

介入

Blood Collection, processing and analyses(PROCEDURE)

Gastroscopy and biopsies collection(PROCEDURE)

Urea Breath Test(DIAGNOSTIC_TEST)

依頼者（Sponsor）

Yonsei University(OTHER)

Stanford University(OTHER)

Singapore General Hospital(OTHER)

Tan Tock Seng Hospital(OTHER)

Chinese University Of Hong Kong(OTHER)

Nihon University(OTHER)

National University Hospital, Singapore(OTHER)

National Taiwan University Hospital(OTHER)

実施施設 (1)

日本大学医学部徳沢診療所

Tokyo, Japan